Joshua Snyder
Overview:
I am the PI of the Cancer Initiation and Cancer Cell Behavior lab. Our research objective is to determine how cancer cells adapt and grow before cancer is diagnosed. Our lab is also part of the Center for Applied therapeutics where we share our models as tools for preclinical and translational research. To learn more about our research please visit the Cancer Initiation and Cancer Cell Behavior Lab's homepage.
Positions:
Associate Professor in Surgery
Surgery, Surgical Sciences
School of Medicine
Associate Professor of Cell Biology
Cell Biology
School of Medicine
Associate Professor in Pharmacology and Cancer Biology
Pharmacology & Cancer Biology
School of Medicine
Member of the Duke Cancer Institute
Duke Cancer Institute
School of Medicine
Education:
Ph.D. 2009
University of Pittsburgh, School of Medicine
Grants:
Establishing the molecular and cellular mechanisms of Lgr5 signaling for controlling cancer stem cell behavior
Administered By
Surgery, Surgical Sciences
Awarded By
National Institutes of Health
Role
Principal Investigator
Start Date
End Date
A Cancer Rainbow Mouse for Simultaneous Assessment of Multiple Oncogenes
Administered By
Basic Science Departments
Awarded By
National Institutes of Health
Role
Assistant Research Professor
Start Date
End Date
Beta-catenin modulates dopamine dependent signal transduction and behavior.
Administered By
Basic Science Departments
Awarded By
National Institutes of Health
Role
PI-Fellow
Start Date
End Date
Only the strong survive: Microenvironmental and genetic determinants of organotropism
Administered By
Surgery, Surgical Sciences
Awarded By
Sage Bionetworks
Role
Principal Investigator
Start Date
End Date
Establishing the molecular and cellular mechanisms of Lgr5 signaling for controlling cancer stem cell behavior
Administered By
Surgery, Surgical Sciences
Awarded By
National Institutes of Health
Role
Principal Investigator
Start Date
End Date
Publications:
A LGR5 reporter pig model closely resembles human intestine for improved study of stem cells in disease.
Intestinal epithelial stem cells (ISCs) are responsible for intestinal epithelial barrier renewal; thereby, ISCs play a critical role in intestinal pathophysiology research. While transgenic ISC reporter mice are available, advanced translational studies lack a large animal model. This study validates ISC isolation in a new porcine Leucine Rich Repeat Containing G Protein-Coupled Receptor 5 (LGR5) reporter line and demonstrates the use of these pigs as a novel colorectal cancer (CRC) model. We applied histology, immunofluorescence, fluorescence-activated cell sorting, flow cytometry, gene expression quantification, and 3D organoid cultures to whole tissue and single cells from the duodenum, jejunum, ileum, and colon of LGR5-H2B-GFP and wild-type pigs. Ileum and colon LGR5-H2B-GFP, healthy human, and murine biopsies were compared by mRNA fluorescent in situ hybridization (FISH). To model CRC, adenomatous polyposis coli (APC) mutation was induced by CRISPR/Cas9 editing in porcine LGR5-H2B-GFP colonoids. Crypt-base, green fluorescent protein (GFP) expressing cells co-localized with ISC biomarkers. LGR5-H2B-GFPhi cells had significantly higher LGR5 expression (p < .01) and enteroid forming efficiency (p < .0001) compared with LGR5-H2B-GFPmed/lo/neg cells. Using FISH, similar LGR5, OLFM4, HOPX, LYZ, and SOX9 expression was identified between human and LGR5-H2B-GFP pig crypt-base cells. LGR5-H2B-GFP/APCnull colonoids had cystic growth in WNT/R-spondin-depleted media and significantly upregulated WNT/β-catenin target gene expression (p < .05). LGR5+ ISCs are reproducibly isolated in LGR5-H2B-GFP pigs and used to model CRC in an organoid platform. The known anatomical and physiologic similarities between pig and human, and those shown by crypt-base FISH, underscore the significance of this novel LGR5-H2B-GFP pig to translational ISC research.
Authors
Schaaf, CR; Polkoff, KM; Carter, A; Stewart, AS; Sheahan, B; Freund, J; Ginzel, J; Snyder, JC; Roper, J; Piedrahita, JA; Gonzalez, LM
MLA Citation
Schaaf, Cecilia R., et al. “A LGR5 reporter pig model closely resembles human intestine for improved study of stem cells in disease.” Faseb J, vol. 37, no. 6, June 2023, p. e22975. Pubmed, doi:10.1096/fj.202300223R.
URI
https://scholars.duke.edu/individual/pub1575605
PMID
37159340
Source
pubmed
Published In
Faseb Journal : Official Publication of the Federation of American Societies for Experimental Biology
Volume
37
Published Date
Start Page
e22975
DOI
10.1096/fj.202300223R
Supplementary Figure 7 from HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase
<jats:p><p>mRNA FISH of cell state markers</p></jats:p>
Authors
Ginzel, JD; Acharya, CR; Lubkov, V; Mori, H; Boone, PG; Rochelle, LK; Roberts, WL; Everitt, JI; Hartman, ZC; Crosby, EJ; Barak, LS; Caron, MG; Chen, JQ; Hubbard, NE; Cardiff, RD; Borowsky, AD; Lyerly, HK; Snyder, JC
MLA Citation
Ginzel, Joshua D., et al. Supplementary Figure 7 from HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase. 3 Apr. 2023. Crossref, doi:10.1158/1541-7786.22526384.
URI
https://scholars.duke.edu/individual/pub1571964
Source
crossref
Published Date
DOI
10.1158/1541-7786.22526384
Supplementary Tables 1-5 for scRNAseq marker genes from HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase
<jats:p><p>Supplementary Table 1: Cluster-specific markers from all cells (8,486 cells) Supplementary Table 2: Cluster-specific markers from all epithelial cells (3,843 cells) Supplementary Table 3: Cluster-specific markers from all immune cells (1,803 cells) Supplementary Table 4: Cluster-specific markers from all fibroblast cells (922 cells) Supplementary Table 5a: State-specific markers from all d16:HBOW epithelial cells (1,421 cells) Supplementary Table 5b: State-specific markers from all p95:HBOW epithelial cells (1,258 cells)</p></jats:p>
Authors
Ginzel, JD; Acharya, CR; Lubkov, V; Mori, H; Boone, PG; Rochelle, LK; Roberts, WL; Everitt, JI; Hartman, ZC; Crosby, EJ; Barak, LS; Caron, MG; Chen, JQ; Hubbard, NE; Cardiff, RD; Borowsky, AD; Lyerly, HK; Snyder, JC
MLA Citation
Ginzel, Joshua D., et al. Supplementary Tables 1-5 for scRNAseq marker genes from HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase. 3 Apr. 2023. Crossref, doi:10.1158/1541-7786.22526378.v1.
URI
https://scholars.duke.edu/individual/pub1571980
Source
crossref
Published Date
DOI
10.1158/1541-7786.22526378.v1
Supplementary Figure 4 from HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase
<jats:p><p>MaXFISH coregistry of sequenced tumors</p></jats:p>
Authors
Ginzel, JD; Acharya, CR; Lubkov, V; Mori, H; Boone, PG; Rochelle, LK; Roberts, WL; Everitt, JI; Hartman, ZC; Crosby, EJ; Barak, LS; Caron, MG; Chen, JQ; Hubbard, NE; Cardiff, RD; Borowsky, AD; Lyerly, HK; Snyder, JC
MLA Citation
Ginzel, Joshua D., et al. Supplementary Figure 4 from HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase. 3 Apr. 2023. Crossref, doi:10.1158/1541-7786.22526393.
URI
https://scholars.duke.edu/individual/pub1571965
Source
crossref
Published Date
DOI
10.1158/1541-7786.22526393
Supplementary Figure 3 from HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase
<jats:p><p>UMAP clustering of sequenced cells and cluster identification</p></jats:p>
Authors
Ginzel, JD; Acharya, CR; Lubkov, V; Mori, H; Boone, PG; Rochelle, LK; Roberts, WL; Everitt, JI; Hartman, ZC; Crosby, EJ; Barak, LS; Caron, MG; Chen, JQ; Hubbard, NE; Cardiff, RD; Borowsky, AD; Lyerly, HK; Snyder, JC
MLA Citation
Ginzel, Joshua D., et al. Supplementary Figure 3 from HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase. 3 Apr. 2023. Crossref, doi:10.1158/1541-7786.22526396.v1.
URI
https://scholars.duke.edu/individual/pub1571981
Source
crossref
Published Date
DOI
10.1158/1541-7786.22526396.v1

Associate Professor in Surgery
Contact:
203 Research Drive, Msrb1 475A, DUMC 2606, Durham, NC 27710
Msrbi Rm 475A, Durham, NC 27710